Passage Bio, Inc. (PASG)

Passage Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	46.3	37.57	21.71	34.6	128.97
Short-Term Investments	-	39.18	92.59	155.01	186.81
Cash & Short-Term Investments	46.3	76.76	114.29	189.61	315.77
Cash Growth	-39.67%	-32.84%	-39.72%	-39.95%	3.59%
Other Current Assets	1.46	2.06	3.67	7.43	9.29
Total Current Assets	47.76	78.82	117.96	197.04	325.07
Net Property, Plant & Equipment	14.28	23.13	32.15	42.24	23.81
Other Long-Term Assets	0.24	0.46	0.43	4.27	6.2
Total Assets	62.28	102.41	150.55	243.55	355.08
Accounts Payable	1.11	0.74	1.3	4.07	9.45
Accrued Expenses	4.65	6.71	11.67	11.01	20.05
Current Portion of Leases	3.57	3.69	3.37	3.28	-
Unearned Revenue	13.75	8.23	-	-	-
Total Current Liabilities	23.08	19.36	16.34	18.35	29.5
Long-Term Leases	20.44	21.79	22.92	23.83	-
Other Long-Term Liabilities	-	-	-	-	6.92
Total Long-Term Liabilities	20.44	21.79	22.92	23.83	6.92
Total Liabilities	43.53	41.15	39.26	42.18	36.42
Common Stock	-	-	0.01	0.01	0.01
Additional Paid-in Capital	723.51	720.49	705.79	694.73	675.35
Accumulated Other Comprehensive Income	0.01	-	-0.04	-0.97	-0.41
Retained Earnings	-704.76	-659.24	-594.47	-492.41	-356.28
Shareholders' Equity	18.76	61.25	111.28	201.37	318.66
Total Liabilities & Equity	62.29	102.4	150.55	243.55	355.08
Total Debt	24.01	25.48	26.29	27.11	0
Net Cash (Debt)	22.29	51.28	88	162.5	315.77
Net Cash Growth	-56.53%	-41.73%	-45.85%	-48.54%	3.59%
Net Cash Per Share	7.03	16.66	32.15	59.71	118.39
Book Value	18.76	61.25	111.28	201.37	318.66
Book Value Per Share	5.91	19.90	40.66	73.99	119.47
Tangible Book Value	18.76	61.25	111.28	201.37	318.66
Tangible Book Value Per Share	5.91	19.90	40.66	73.99	119.47

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q